The 2 analysts offering 1 year price forecasts for SQURPHARMA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to SQURPHARMA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
According to analysts, SQURPHARMA price target is 306.20 BDT with a max estimate of 309.40 BDT and a min estimate of 303.00 BDT. Check if this forecast comes true in a year, meanwhile watch SQUARE PHARMACEUTICALS PLC stock price chart and keep track of the current situation with SQURPHARMA news and stock market news.